Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

United Therapeutics (UTHR) Exchange Rate Effect (2016 - 2017)

United Therapeutics' Exchange Rate Effect history spans 9 years, with the latest figure at -$200000.0 for Q3 2017.

  • For Q3 2017, Exchange Rate Effect rose 80.0% year-over-year to -$200000.0; the TTM value through Dec 2017 reached -$1.4 million, up 53.33%, while the annual FY2017 figure was $200000.0, 106.67% up from the prior year.
  • Exchange Rate Effect for Q3 2017 was -$200000.0 at United Therapeutics, roughly flat from -$200000.0 in the prior quarter.
  • Across five years, Exchange Rate Effect topped out at $1.5 million in Q2 2015 and bottomed at -$3.1 million in Q1 2015.
  • The 5-year median for Exchange Rate Effect is -$295000.0 (2013), against an average of -$742294.1.
  • The largest YoY upside for Exchange Rate Effect was 374.68% in 2015 against a maximum downside of 1912.99% in 2015.
  • A 5-year view of Exchange Rate Effect shows it stood at -$295000.0 in 2013, then plummeted by 892.54% to -$2.9 million in 2014, then soared by 45.36% to -$1.6 million in 2015, then skyrocketed by 87.5% to -$200000.0 in 2016, then changed by 0.0% to -$200000.0 in 2017.
  • Per Business Quant, the three most recent readings for UTHR's Exchange Rate Effect are -$200000.0 (Q3 2017), -$200000.0 (Q4 2016), and -$1.0 million (Q3 2016).